Cancel

Burst Expert Illustrations and Commentaries™: Visualizing Gene Therapy Approaches in Hemophilia A

Target Audience This educational activity is directed toward hematologists, pediatricians, and primary care clinicians, medical geneticists, nurses, and other healthcare professionals who care for patients with hemophilia. Activity Overview This Burst Expert Illustrations and Commentaries™ is a video-based program in which an expert discusses the etiology and emerging treatment of hemophilia A. In this activity, the faculty focuses on the pathophysiology of hemophilia A relevant to ...
Physicians’ Education Resource®, LLC

Answering the Call: Nurse-Led Strategies to Improve Compliance with Hemophilia Prophylaxis

Prophylactic management of hemophilia continues to be a challenge. The nurse-led activity discusses treatment strategies, safety and efficacy of current available products, and how to improve patient adherence. In this clinical commentary Kerry H. Hansen, RN, BS and Skye Peltier, MPH, PA-C review best practices to facilitate successful therapeutic interventions with hemophilia A Kerry H. Hansen, RN, BS and Skye Peltier, MPH, PA-C
ACHL

Answering the Call: Nurse-Led Strategies to Improve Compliance with Hemophilia Prophylaxis

Target Audience This educational activity is designed for advanced practice nurses (APRN) including nurses and nurse practitioners (NP), physicians, and other clinicians in a hematology setting treating patients with hemophilia A Program Overview Prophylactic management of hemophilia continues to be a challenge. The nurse-led activity discusses treatment strategies, safety and efficacy of current available products, and how to improve patient adherence. In this clinical commentary, expert...
Relias LLC

Medical Crossfire®: Personalized Regimens for Managing Hemophilia A: Selecting an Optimal Recombinant FVIII Agent

Target Audience This online educational activity is directed toward hematologists, primary care clinicians, nurse practitioners, physician assistants, nurses, and other health care professionals who are involved in the management of hemophilia. Activity Overview Over the past 20 years, substantial advances in the treatment of hemophilia A have allowed patients to take greater control of their disease. The primary goals of hemophilia A treatment are to prevent bleeding episodes, reduce lon...
Relias LLC

Evaluating Emerging Gene Therapies to Further Treatment for Patients with Hemophilia A

Target Audience This initiative is intended for hemophilia specialists, hematologists, emergency department clinicians, nurses, medical geneticists, genetic counselors, and other healthcare providers who care for patients with hemophilia A. Program Overview Hemophilia A is an inherited bleeding disorders due to the partial or total deficiency of coagulation factor (F) VIII. Progress in hemophilia therapy has been remarkable over the last decades with the development of efficacious the...
AKH Inc., Advancing Knowledge in Healthcare and Catalyst Medical Education, LLC.

Clinical Complications, Challenges, and Comorbidities Assoicated with Hemophilia A and its Treatment

Target Audience This initiative is intended for hemophilia specialists, hematologists, emergency department clinicians, nurses, medical geneticists, genetic counselors, and other healthcare providers who care for patients with hemophilia A. Program Overview Hemophilia A is an inherited bleeding disorders due to the partial or total deficiency of coagulation factor (F) VIII. Progress in hemophilia therapy has been remarkable over the last decades with the development of efficacious the...
Sanofi Genzyme and Takeda Pharmaceuticals U.S.A., Inc.

Managing the Whole Patient with Hemophilia A: Clinical Evidence and Practical Strategies

Target Audience This educational program is directed toward hematologists and hematologist-oncologists. Pediatricians, nurses, nurse practitioners, physician assistants, and other clinicians involved in the management of patients with hemophilia are invited to attend. Program Overview Over the past 20 years, numerous advances in hemophilia treatment have allowed patients to take greater control of their condition. To continue capitalizing on these advances, hematologists must be educated ...
Physicians’ Education Resource®, LLC

Selecting and Dosing Clotting Factors to Individualize Treatment for Patients with Hemophilia A

Target Audience This initiative is intended for hemophilia specialists, hematologists, emergency department clinicians, nurses, medical geneticists, genetic counselors, and other healthcare providers who care for patients with hemophilia A. Program Overview Hemophilia A is an inherited bleeding disorders due to the partial or total deficiency of coagulation factor (F) VIII. Progress in hemophilia therapy has been remarkable over the last decades with the development of efficacious the...
AKH Inc., Advancing Knowledge in Healthcare and Catalyst Medical Education, LLC.

Expanding Patient Engagement to Advance Hemophilia A Treatment Adherence and Outcomes

Target Audience This initiative is intended for hemophilia specialists, hematologists, emergency department clinicians, nurses, medical geneticists, genetic counselors, and other healthcare providers who care for patients with hemophilia A. Program Overview Hemophilia A is an inherited bleeding disorders due to the partial or total deficiency of coagulation factor (F) VIII. Progress in hemophilia therapy has been remarkable over the last decades with the development of efficacious the...
AKH Inc., Advancing Knowledge in Healthcare and Catalyst Medical Education, LLC.

Community Practice Connections™: New Horizons in Hemophilia: Preparing for the Advent of Gene Therapy

Target Audience This educational program is directed toward hematologists, specialty NPs, PAs, and RNs. Pediatricians, emergency medicine clinicians, and other HCPs involved in the management of patients with hemophilia are invited to participate. Program Overview Hemophilia A is caused by a mutation in the gene coding for coagulation factor VIII (FVIII), resulting in the loss of functional FVIII protein. FVIII is a critical cofactor for factor IX (FIX), which is deficient in patients wit...
Physicians’ Education Resource®, LLC

Emerging Nonfactor Approaches for Patients with Hemophilia: Enhancing and Rebalancing Therapies

Target Audience This educational activity is intended for HCPs who care for patients with hemophilia, including hematologists and advanced practice professionals (nurse practitioners and physician assistants). Program Overview This interactive learning module is a self-directed educational activity, led by experts Dr. Michelle Sholzberg and Dr. Angela Weyand. Topics include new and emerging treatments, novel agents that are being developed, current clinical studies and potential concerns ...
The France Foundation. This activity was produced in collaboration with the International Society on Thrombosis and Haemostasis

CORE Higher Education Group, CESearchEngine.com, and our advertising partners do not endorse and do not verify the accuracy of the content in the activities presented on the CESearchEngine.com website or within our mobile apps.CORE Higher Education Group, CESearchEngine.com, and our advertising partners are not responsible for errors, omissions, or misrepresentations contained within activities presented on the CESearchEngine website or within our mobile apps. For complete details, please read the CESearchEngine.com Terms of Service. Site Map